Details

Biomarkers for predicting malignant transformation of premalignant lesions of the larynx : a systematic review
ID Rodrigo, Juan Pablo (Author), ID Zidar, Nina (Author), ID Gale, Nina (Author), et al.

.pdfPDF - Presentation file, Download (1,41 MB)
MD5: C2F10EC30C262874668C8CBC9B646922
URLURL - Source URL, Visit https://www.mdpi.com/2075-4418/16/2/236 This link opens in a new window

Abstract
Background/Objectives: Premalignant laryngeal lesions carry a variable risk of malignant transformation to squamous cell carcinoma. Identifying reliable biomarkers that predict malignant transformation could improve patient management and surveillance strategies. The objective of this work is to perform a systematic review of the literature on biomarkers that predict malignant transformation of premalignant laryngeal lesions. Methods: We conducted a systematic review following PRISMA 2020 guidelines. The PubMed, Scopus and Embase databases, and Google Scholar were searched for studies published between January 2011 and November 2025. Studies investigating biomarkers that predict malignant transformation of histopathologically confirmed premalignant laryngeal lesions were included. Risk of bias was assessed using the ROBINS-I tool. Results: From 166 initially identified records, 11 studies met the inclusion criteria, including 730 patients. These studies investigated diverse biomarker categories such as protein markers (cortactin, FAK, NANOG, SOX2, CSPG4), immune markers (tumor-infiltrating lymphocytes, immune gene signatures), microRNAs (miR-183-5p, miR-155-5p, miR-106b-3p), and genetic markers (chromosomal instability, PIK3CA amplification and mutations, FGFR3 mutations). Five studies provided adequate follow-up data on transformation outcomes. Most studies showed a moderate to serious risk of bias primarily due to limited confounder control and incomplete reporting. Conclusions: While several promising biomarker candidates have been identified, the evidence base remains limited due to small sample sizes, heterogeneous methodologies, and inadequate follow-up data. Cortactin/FAK protein expression and immune signatures are the most promising but require validation in larger, well-designed prospective cohorts.

Language:English
Keywords:ROBINS-I, biomarkers, laryngeal dysplasia, malignant transformation, premalignant lesions, systematic review
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:14 str.
Numbering:Vol. 16, iss. 2, art. 236
PID:20.500.12556/RUL-183304 This link opens in a new window
UDC:616-006
ISSN on article:2075-4418
DOI:10.3390/diagnostics16020236 This link opens in a new window
COBISS.SI-ID:267970563 This link opens in a new window
Publication date in RUL:11.06.2026
Views:284
Downloads:211
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Diagnostics
Shortened title:Diagnostics
Publisher:MDPI
ISSN:2075-4418
COBISS.SI-ID:519963673 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:ROBINS-I, biološki označevalci, displazija grla, maligna transformacija, premaligne lezije, sistematični pregled

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back